For consumers
Learn how to safely access and use different health products in Australia.
-
Travelling with medicines and medical devices
If you're travelling to or from Australia, bring your medicines or medical devices with you. -
Vapes: information for individuals and patients
Find out about therapeutic vapes for smoking cessation and the management of nicotine dependence, how they are regulated, and how they can be accessed. -
Medicine shortages information for consumers
Understand medicine shortages and what to do if your medicine is affected.
For industry
Understand your obligations and access resources to support your work.
-
Guidance
Our Guidance explains the laws and regulations governing the development, manufacturing, marketing, and supply of therapeutic goods in Australia. -
Australian Regulatory Guidelines (ARGs)
The ARGs group together resources about regulatory requirements for biologicals, medical devices and medicines. -
For health professionals
Access product information and safety updates to support your practice.
-
Vapes: information for prescribers
Learn about the regulatory framework for prescribing therapeutic vapes for smoking cessation or the management of nicotine dependence. -
Safety updates
Refer to our articles for health professionals about health products and emerging safety issues. -
Medicine shortages information for health professionals
General medicine shortage information and what to do if your patient’s medicine is in shortage.
Alerts
-
Safety alerts
Refer to the latest safety alerts for medicines or medical devices with possible risks. -
-
How to make a report
-
Report a medicine or vaccine defect
Use this form to report defects that you think have arisen during manufacture, storage or handling of a medicine or vaccine. -
Reporting adverse events for consumers
How to report a side effect, reaction or other problem with a therapeutic good. Your report can help keep others safe. -
Reporting medical device incidents for sponsors and manufacturers
Industry portal - Log in to report medical device incidents via the Medical Device Incident Reporting (MDIR) system. -
Report a perceived breach or questionable practices
Use this form to report a perceived breach of the Therapeutic Goods Act, counterfeit products or questionable practices in relation to therapeutic products.
-
Report non-compliant advertising
Use this portal to report a non-compliant advertisement for a medicine, medical device or any other type of therapeutic good.
Key resources
-
Legislation
Find listed information for the legislation that is referred to in our Guidance content. -
Guidance
Our Guidance explains the laws and regulations governing the development, manufacturing, marketing, and supply of therapeutic goods in Australia. -
Resources
Search our resources for checklists, user guides, international scientific guidelines, compositional guidelines and forms. -
-
Datasets
Search the Australian Register of Therapeutic Goods (ARTG), and safety alerts, product shortages, approvals, and regulatory actions. -
Decision trees
Use decision trees to check rules for therapeutic goods in Australia, including classification, reporting obligations, advertising requirements and supply pathways. -
Transactions
See a list of transactions which provide overview information about applications and submissions.
Latest articles
-
What to know if you've been prescribed medicinal cannabis
BlogUnderstanding the difference between an approved and unapproved therapeutic good can help you make informed decisions and have meaningful conversations with your healthcare practitioner, especially when considering treatments like medicinal cannabis. -
Lapse of provisional registration for Andexxa (andexanet alfa) used for Factor Xa inhibitor (apixaban/rivaroxaban) reversal
News articlesANDEXXA is no longer provisionally approved for use in Australia and has been removed from the Australian Register of Therapeutic Goods (ARTG). -
Individual issued 27 infringement notices for allegedly supplying Melanotan II
Media releasesWe have issued 27 infringement notices, totalling $101,412, to a NSW-based individual for the alleged unlawful supply of Melanotan II to Australian consumers in contravention of the Therapeutic Goods Act 1989.
Latest publications
-
Scheduling decisions (final)This web publication constitutes a notice for the purposes of regulation 42ZCZX of the Therapeutic Goods Regulations 1990 (the Regulations).
-
Corporate reportsThis report provides information about the TGA’s regulatory performance for the 2024-25 financial year.
-
Meeting statementsCommunique from the 12th meeting of the Women's Health Products Working Group, 31 March 2026.